Navigation Links
Nosey Camera Could Bring Relief to 4 Million Brits
Date:10/31/2011

LONDON, October 31, 2011 /PRNewswire/ --

New tools build upon company's minimally-invasive Balloon Sinuplasty™ Platform to improve visualisation capabilities during sinus surgery for the treatment of chronic rhinosinusitis.

Millions of patients in the UK who suffer from nasal and sinus problems could be brought relief by two innovative technologies to help clear nasal blockages.

Sinusitis is the most common sinus related illness in the UK, with around nine million sufferers and is caused when the delicate membranes in the sinus become inflamed, causing a blockage.

The symptoms of sinusitis can include: pressure headaches, facial pain, nasal obstruction, toothache and fatigue.

Two new technologies, the Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System, allow surgeons to navigate the sinus with an exceptional field of vision to check for any blockages or potential problems.

The sinuses are the air spaces behind the bones of the upper face, between the eyes and behind the forehead, nose and cheeks. The sinuses are narrow and tortuous anatomy, and even relatively minor inflammation can present a major obstacle.

Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System allows the surgeon to directly visualise the natural opening of the sinuses, even parts which are just a few millimeters wide, and examine many angles with one scope.

The two innovations were developed by Acclarent, Inc. who also introduced Balloon Sinuplasty™, a technique in which a tiny balloon is guided into the sinuses to help clear blockages in the sinus in an effective manner.

The treatment has been hugely successful and since Balloon Sinuplasty was launched in 2005, more than 120,000 patients have been treated with the medical procedure.

For further information please visit http://www.balloonsinuplasty.co.uk

For more information on chronic sinusitis treatment visit: http://www.balloonsinuplasty.co.uk/sinusitis-facts/chronic-sinusitis-treatment-options/ and for information on sinus surgery visit: http://www.balloonsinuplasty.co.uk/sinusitis-facts/sinus-surgery/

About the Balloon Sinuplasty™ System: Since 2005, more than 120,000 patients have been treated with Balloon Sinuplasty technology in operating rooms and office settings. Acclarent's comprehensive visualisation capabilities enable surgeons to confidently access, dilate and irrigate targeted sinuses throughout every aspect of Endoscopic Sinus Surgery (ESS) with Balloon Sinuplasty technology and provide their patients with minimally invasive options that have been repeatedly proven safe and effective worldwide.

Acclarent, Inc.

Acclarent is a global medical technology company dedicated to the development of innovative products to further meet the needs of ENT surgeons and their patients. Based in Menlo Park, Calif., the company operates as a business unit of Ethicon, Inc., a Johnson & Johnson company.  Through its core technologies and commitment to innovation, Acclarent will continue to advance novel technologies in all areas of ENT. Acclarent markets and sells its products worldwide and its technology has been used by thousands of physicians. For more information about Acclarent, visit http://www.Acclarent.com.


'/>"/>
SOURCE Balloon Sinuplasty(TM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
2. MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras
3. Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
4. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
5. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
6. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
7. Mayo Clinic Study Shows Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
8. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
9. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
10. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
11. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent Medical, ... Aufnahme von Patienten für eine Studie zur Sicherheit ... („WEB") speziell für die Behandlung von rupturierten intrakraniellen ... MD, Leiter der Neuroradiologie an der Universitätsklinik Bicètre ... Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten aufgenommen. ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company (NYSE: ... decided the Alimta® (pemetrexed disodium) vitamin regimen patent would not ... UK, France , Italy ... dilute the product only with dextrose solution.  ... the UK Court of Appeal held that Lilly,s patent would ...
(Date:2/12/2016)... Ungarn, February 12, 2016 ... sich auf den ungedeckten medizinischen Bedarf bei ... Ergebnisse seines klinischen Forschungsprogramms bekannt. Das Programm, ... ergab Verbesserungen ihrer respiratorischen Funktionen und anderer ... , ein Medizintechnikunternehmen, das sich auf den ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... According to an ... beginning to account for a significant portion of hernia repairs throughout the United States. ... Beverly Hills Hernia Center notes that this trend has not only been expected, but ...
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted over 250 members of South Florida’s philanthropic community at its 10th ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... As a ... hectic schedule, a demanding job, and no time to decompress, Rabinowitz found herself drawn ... herself to meditation for its impact on her life, implementing a 20-minute-per-day meditation practice ...
(Date:2/12/2016)... ... 2016 , ... Itopia, a leader in cloud services automation ... Platform (CIP) into Cielo®, a discovery, migration and cloud orchestration engine. This integration ... and medium business (SMB) clients. , In recent years, BI and ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a family ... eastern Texas, is launching a cooperative charity drive with the Tarrant Area Food Bank ... than 50,000 individuals and families in need, the Tarrant County Food Bank offers hope ...
Breaking Medicine News(10 mins):